Pediatrix Medical Group (MD) Stock: Buy, Sell, or Hold?
MD - Pediatrix Medical Group, Inc.
$26.77
0.04 (0.15%)
â˛
5d:
-0.41%
30d:
+1.02%
90d:
+10.8%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 02, 2026
Get Alerted When MD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: MD is fairly priced but lacks strong directional signals. At 3.5% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: MD is fairly priced but lacks strong directional signals. At 3.5% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$29.32
Based on 4.0% avg growth
INTRINSIC VALUE TODAY
$18.20
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: MD is currently trading at $26.77, which is considered slightly high relative to its 30-day fair value range of $26.06 to $27.00. From a valuation perspective, the stock is trading at a premium (Forward PE: 11.0) compared to its historical average (9.9). At these levels, the market is pricing in 3.5% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MD is in a strong uptrend. The price is approaching resistance at $27.56. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MD is in a strong uptrend. The price is approaching resistance at $27.56. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$26.06 -
$27.00
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.4%
All Signals
- NEUTRAL: Mixed technical signals (43/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($26.33)
- NEUTRAL: Market pricing in 3.5% annual earnings growth - fairly valued
- WARNING: Composite score 52/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$26.06 -
$27.00
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$25.33
Resistance Level
$27.56
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
10.97
Wall Street Target
$26.33
(-1.6%)
Revenue Growth (YoY)
4.0%
Earnings Growth (YoY)
6.5%
Profit Margin
9.0%
Valuation Premium vs History
+3.5% premium
PE vs Historical
11.0 vs 9.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.5%
(market-implied from PE analysis)
1-Year Target
$27.71
(+4%)
2-Year Target
$28.68
(+7%)
3-Year Target
$29.68
(+11%)
3-Yr Target (if PE normalizes)
(PE: 11â10)
PE COMPRESSION
$26.78
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 3.9%)
$55.17
(+106%)
Base:
(SPY PE: 11.0, Growth: 3.9%)
$30.02
(+12%)
Bear:
(PE: 9.3, Growth: 3.9%)
$25.51
(-5%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (13x PE), but valuation improves significantly next year (11x PE) as earnings recover.
Trailing PE: 12.79 | Current EPS (TTM): $2.09
Bull Case
$34.32
(+28%)
Analyst growth 16.7%, PE expands to 14.1
Base Case
$31.20
(+17%)
Market implied 16.7%, PE stable at 12.8
Bear Case
$18.18
(-32%)
Severe decline -20.0%, PE contracts to 10.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: September 12, 2026 9:37 AM ET
Data refreshes hourly during market hours. Next update: 10:37 AM
Data refreshes hourly during market hours. Next update: 10:37 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare CorporaâĻ |
STRONG BUY
22 analysts |
$285 | 61 BUY |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$451 | 50 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$148 | 55 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 52 HOLD |
|
ADUS
Addus HomeCare CorporatiâĻ |
STRONG BUY
11 analysts |
$135 | 56 HOLD |
